Who cares about Abbott? We are now Abbvie.
So why are you lurking on the Abbott site? Do you miss Mother Abbott? Go to your AbbVie site.
This is the de facto AbbVie board. In case you haven't realized this yet, Abbott is not much of a pharma company anymore.
Not true - unfortunately Cafepharma is US centric, but Abbott makes more than 5 billion with old drugs worldwide - called EPD with extraordinary growth rates in the emerging markets. Bausch&Lomb is also selling drugs beside medical devices and nutrition.
Sure the growth rate is there, but the profit margin sucks. More countries are taking the IP of pharmas and making it their own at worst, and mandating pricing cuts at best.
Not true - unfortunately Cafepharma is US centric, but Abbott makes more than 5 billion with old drugs worldwide - called EPD with extraordinary growth rates in the emerging markets. Bausch&Lomb is also selling drugs beside medical devices and nutrition.
Yep, huge growth potential. But here's another 15 -20% hit on prices by China:
"Pharma's path to a big payoff in China is growing narrower and narrower. The government has just announced its fourth drug-price cut since 2011, with 400 meds subject to forced discounts. And on that list are several of Big Pharma's key products.
In a statement issued earlier today, China's National Development and Reform Commission outlined 20 classes of drugs affected, including respiratory remedies, pain relievers and--for the first time--specialty drugs. The average hit will be 15%, with cuts to the more expensive drugs running as high as 20%, Reuters reports."
Yep, huge growth potential. But here's another 15 -20% hit on prices by China:
"Pharma's path to a big payoff in China is growing narrower and narrower. The government has just announced its fourth drug-price cut since 2011, with 400 meds subject to forced discounts. And on that list are several of Big Pharma's key products.
In a statement issued earlier today, China's National Development and Reform Commission outlined 20 classes of drugs affected, including respiratory remedies, pain relievers and--for the first time--specialty drugs. The average hit will be 15%, with cuts to the more expensive drugs running as high as 20%, Reuters reports."